Gordon Joseph F's Form 4 filing
Bausch Health Companies Inc. (BHC) · filed Mar 2, 2022
- Accession no.
- 0000899243-22-008830
- Filed
- Mar 2, 2022
- Trade date
- Feb 26-Mar 1, 2022
- Filing delay
- 4 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $151.0K. It was filed 4 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gordon Joseph FCIK 0001749876 | Officer (Pres&Co-Head Bausch&Lomb/Int'l) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2022 | Common Shares, No Par Value | MOption exerciseAcquired | +17,350 | –F2 | – | 127,988 | Direct | |
| Feb 27, 2022 | Common Shares, No Par Value | FTax withholdingDisposed | −6,233 | $24.35 | −$151,773.55 | 121,755 | Direct | |
| Feb 26, 2022 | Common Shares, No Par Value | FTax withholdingDisposed | −1,522 | $24.35 | −$37,060.7 | 120,233 | Direct | |
| Feb 27, 2022 | Common Shares, No Par Value | FTax withholdingDisposed | −1,716 | $24.35 | −$41,784.6 | 118,517 | Direct | |
| Mar 1, 2022 | Common Shares, No Par Value | SSaleDisposed | −6,338 | $23.82 | −$150,971.16 | 112,179 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2022 | Common Shares, No Par Value | AGrant or awardAcquired | +17,350 | –F2 | – | 0 | Direct | |
| Feb 27, 2022 | Common Shares, No Par Value | MOption exerciseDisposed | 0 | $24.35 | −$422,472.5 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Each PSU converts into Common Shares on a one-for-one basis
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.